Table 4.

Molecular response in patients with Ph⁺ ALL

Molecular response category*	No. of patients (%)
Total no. of patients	37
MMR	6 (16.2)†
CMR	25 (67.5)
CMR at 3 mo	8
CMR at 3-6 mo	5
CMR at >6 mo	12

^*MMR: ≤0.1% BCR-ABL according to the international scale as measured by real-time qPCR; CMR or MR4.0: detectable disease ≤0.01% BCR-ABL (IS) or undetectable disease in cDNA with ≥10 000 ABL transcripts.

^†Time of achievement of MMR: 4 patients achieve within 6 mo, other 2 achieve after 6 mo.